Integrated Proteins Ltd
Integrated Proteins Ltd (INTEGFD) last reported results for the quarter ended Mar 2014, with sales of ₹0.06 crore and net profit of ₹0.02 crore. The stock last traded at ₹163, a market capitalisation of ₹305 crore. Over the past 52 weeks the stock has ranged between ₹20.7 and ₹163. Figures are as of 3 Sept 2026 and are not real time.
Integrated Proteins Ltd share price and key metrics
- Current price
- ₹163
- Market cap
- ₹305 cr
- Book value
- ₹6.31
- ROE
- %
- ROCE
- %
- Dividend yield
- 0.00%
- 52w high / low
- 163/20.7
Metrics as of 3 Sept 2026. Not real time.
Track Integrated Proteins Ltd
Cruxal reads every Integrated Proteins Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Integrated Proteins Ltd growth and returns
- 10 Years
- %
- 5 Years
- %
- 3 Years
- %
- TTM
- %
- 10 Years
- %
- 5 Years
- %
- 3 Years
- %
- TTM
- %
- 10 Years
- %
- 5 Years
- 115%
- 3 Years
- 126%
- 1 Year
- 267%
- 10 Years
- %
- 5 Years
- %
- 3 Years
- %
- Last Year
- %
Integrated Proteins Ltd quarterly results
| ₹ crore | Mar 2013 | Dec 2013 | Mar 2014 |
|---|---|---|---|
| Sales | 0 | 0.01 | 0.06 |
| Expenses | 0.02 | 0.02 | 0.07 |
| Operating profit | -0.02 | -0.01 | -0.01 |
| OPM % | — | -100.00% | -16.67% |
| Other income | 0.1 | 0.06 | 0.04 |
| Interest | 0 | 0 | 0 |
| Depreciation | 0.01 | 0.01 | 0.02 |
| Profit before tax | 0.07 | 0.04 | 0.01 |
| Tax % | 0.00% | 0.00% | 0.00% |
| Net profit | 0.08 | 0.05 | 0.02 |
| EPS (₹) | 0.22 | 0.14 | 0.05 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
Integrated Proteins Ltd shareholding pattern
Promoters held 2.24% at Jun 2026, down from 13.04% at Jun 2025.
| % held | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 46.29% | 22.40% | 13.04% | 13.04% | 13.04% | 2.23% | 2.23% | 2.24% |
| Public | 53.70% | 77.60% | 86.96% | 86.95% | 86.95% | 97.77% | 97.77% | 97.76% |
| No. of shareholders | 1,880 | 1,881 | 1,884 | 1,881 | 1,881 | 1,904 | 1,944 | 2,064 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
Integrated Proteins Ltd corporate filings
- Certificate under regulation 74(5) of SEBI (DP) Regulations, 2018Company Updatelow impact
- Integrated Proteins Limited holds AGM on 30th September 2026; passes all resolutions with near-unanimous approval, including appointment of new directors and secretarial auditorAGM/EGMlow impact
Cruxal's analysis: Integrated Proteins Limited conducted its 33rd AGM via video conferencing on 30th…
Read the full analysis - Integrated Proteins Limited conducts AGM on 30th September 2026; appoints new Independent Director and Secretarial Auditor, with no immediate financial disclosures or strategic events announced.Company Updatelow impact
Cruxal's analysis: Integrated Proteins Limited held its AGM via video conferencing on 30th September 2026…
Read the full analysis - Integrated Proteins Limited holds AGM on 30th September 2026; no immediate financial disclosures or strategic events announcedCompany Updatelow impact
Cruxal's analysis: Integrated Proteins Limited conducted its AGM via video conferencing on 30th September…
Read the full analysis - Integrated Proteins Limited conducts AGM on 30th September 2026 via VC/OAVM, approving key resolutions including appointment of directors and auditorsAGM/EGMlow impact
Cruxal's analysis: Integrated Proteins Limited held its AGM on 30th September 2026 through virtual means…
Read the full analysis - Intimation for Closure of Trading WindowInsider Trading / SASTlow impact
- Integrated Proteins Limited announces 33rd Annual General Meeting to be held via Video Conferencing on September 30, 2026Company Updatelow impact
Cruxal's analysis: Integrated Proteins Limited has issued a formal notice for its 33rd Annual General…
Read the full analysis - Integrated Proteins Ltd files Annual Report for the financial year 2025-2026Otherslow impact
Cruxal's analysis: Integrated Proteins Ltd has submitted its annual report for the fiscal year 2025-2026 in…
Read the full analysis - Integrated Proteins Limited completes ISIN activation for stock split to face value of INR 1 per shareCompany Updatelow impact
Cruxal's analysis: Integrated Proteins Limited has confirmed the activation of a new ISIN (INE177M01021) by…
Read the full analysis - Integrated Proteins Limited shareholders approve 1:10 stock split and board appointmentsAGM/EGMmedium impact
Cruxal's analysis: Integrated Proteins Limited has successfully concluded its Extra-Ordinary General Meeting…
Read the full analysis - Integrated Proteins Limited Announces Record Date for 1:10 Stock SplitCorp. Actionlow impact
Cruxal's analysis: Integrated Proteins Limited has fixed Friday, September 4, 2026, as the record date for…
Read the full analysis - Integrated Proteins Limited Announces Share Split and Management Re-appointmentsAGM/EGMlow impact
Cruxal's analysis: Integrated Proteins Limited has conducted an Extraordinary General Meeting (EGM) to seek…
Read the full analysis - Integrated Proteins Limited Reports Significant Revenue and Profit Growth for Q1 FY2027Company Updatehigh impact
Cruxal's analysis: Integrated Proteins Limited has declared its standalone unaudited financial results for…
Read the full analysis - Integrated Proteins Limited reports significant Q1 FY2027 revenue surge to 10.55 crore with net profit of 36.26 lakhBoard Meetinghigh impact
Cruxal's analysis: Integrated Proteins Limited reported a substantial increase in financial performance for…
Read the full analysis - Integrated Proteins Limited schedules Board Meeting for August 14, 2026, to approve Q1 FY27 financial resultsBoard Meetinglow impact
Cruxal's analysis: Integrated Proteins Limited has formally intimated the BSE regarding a Board Meeting…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.